Rezvoglar Injection, Solution
Product Images NDC 0002-8980

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Rezvoglar (NDC 0002-8980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Carton – Rezvoglar Kwikpen Carton (Rezvoglar Kpen 80u Cart 5ct Nl)

Rezvoglar KwikPen (insulin glargine-aglr) injection 100 units per mL (U-100) solution for subcutaneous use. Box contains five 3 mL prefilled pens intended for single patient use, labeled for dispensing in a sealed carton. Manufactured by Eli Lilly and Company. The label includes storage, handling, and usage instructions and a barcode.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 1 V1)

An illustration diagram showing the labeled parts of the Rezvoglar KwikPen injection device. Key components include the pen cap with cap clip, rubber seal, cartridge holder, plunger, pen body with the product label displaying Rezvoglar KwikPen, dose indicator featuring a dose window and dose knob.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 10 V1)

An illustration showing a close-up of the dose selector window on a device, likely an insulin pen, displaying dose levels ranging from 2 to 26 units in increments of 2. A red arrow points specifically at the dose level 24, highlighting dose selection on the pen's dial.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 11 V1)

Instructional illustration showing a hand holding an insulin pen injecting subcutaneously into the abdomen, with an arrow indicating to press the injection button. A stopwatch icon displays "5 sec", indicating the recommended time to hold the pen after injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 12 V1)

An instructional illustration showing a hand holding a Rezvoglar KwikPen insulin injection pen and wrapping the pen with a red ribbon or band, likely demonstrating proper handling or preparation of the device for subcutaneous injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 2 V1)

An instructional illustration showing the parts of a pen needle including the outer needle shield, inner needle shield, paper tab, and needle, along with a depiction of a dose knob featuring a green ring. The pen needle is labeled as not included.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 3 V1)

An instructional diagram showing how to remove a cap from a pen injection device by twisting and pulling the cap off the pen tip.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 4 V1)

An instructional illustration showing a close-up of a Rezvoglar KwikPen dose selector window, with a red arrow pointing upward toward the pen's dose knob, indicating the step to adjust or set the insulin dose for injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 5 V1)

An instructional diagram showing a cap being kept on the left side with an arrow pointing left, and the needle or syringe tip shown on the right side with an instruction to throw away the needle. This likely illustrates safe handling or disposal of components related to an injection device.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 6 V1)

An instructional illustration showing a hand holding a Rezvoglar KwikPen injection device. The image emphasizes pressing a button at the bottom of the pen with an upward arrow, with a zoomed-in view of the needle tip extending from the pen, indicating the injection mechanism for subcutaneous use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 7 V1)

An illustration showing a close-up view of the dose selector window on a Rezvoglar KwikPen insulin injection device. The image highlights the dose indicator scale with a red marker near the zero dose line, indicating a dialed dose setting, and the pen's grip area with indentation details for finger placement.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 8 V1)

An instructional illustration showing a close-up view of a hand holding part of a Rezvoglar KwikPen insulin injection device. The illustration depicts an upward arrow indicating the action of pulling or sliding a component from the pen, likely related to preparing or priming the injection device before use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 9 V1)

An instructional diagram showing a close-up of a device window with a dose indicator displaying the number 12, and an arrow pointing to it, likely illustrating how to read the dose setting on the injection device.*

FDA Label Image

Structural Formula (Rezvoglar Uspi Chem Struct)

Chemical structure diagram showing the amino acid sequence of insulin glargine-aglr. The structure depicts the A-chain and B-chain with labeled amino acids and disulfide bonds connecting specific cysteine residues.*

FDA Label Image

Figure 1 (Rezvoglar Uspi F1)

A line graph depicting glucose infusion rate (mg/kg/min) over time (hours) after subcutaneous injection, comparing Insulin glargine and NPH insulin with data from 20 subjects each. The graph shows glucose infusion rates on the y-axis and time up to 30 hours on the x-axis, with a marker indicating the end of the observation period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.